Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
life sciences
national blog main
san francisco blog main
boston blog main
boston top stories
clinical trials
eli lilly
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
deals
fda
johnson & johnson
medical device
migraine
startups
abbvie
aduro biotech
agenus
What
companies
7
×
drug
7
×
bio
new
roundup
year
approval
biotech
fda
ipo
leading
medicines
migraine
nash
news
price
therapies
activity
alzheimer’s
approved
arguments
backed
big
biogen’s
biopharmaceutical
black
built
cancer
class
clinic
commercialized
competitors
convo
days
decades
diamond
different
digital
discovery
disease
Language
unset
Current search:
drug
×
biotech
×
companies
×
@tech.eu
1 year ago
EU-backed healthcare project rolls out platform for federated learning in drug discovery
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More